SciELO - Scientific Electronic Library Online

 
vol.20 issue6Self-perception of surface hydration effect on teachers’ voice quality: an intervention studyRespiratory muscle training outcomes on swallowing biomechanics and respiratory function measures in normal subjects author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

Share


Revista CEFAC

Print version ISSN 1516-1846On-line version ISSN 1982-0216

Rev. CEFAC vol.20 no.6 São Paulo Nov./Dec. 2018

http://dx.doi.org/10.1590/1982-021620182064218 

ORIGINAL ARTICLES

Osmolality analysis of human milk and an infant formula with modified viscosity for use in infants with dysphagia

Mariangela Bartha de Mattos Almeida1 

Saint Clair Gomes Júnior1 

Jonas Borges da Silva1 

Danielle Aparecida da Silva1 

Maria Elisabeth Lopes Moreira1 

1Instituto Nacional de Saúde da Mulher, da Criança e do Adolescente Fernandes Figueira - IFF/ Fundação Oswaldo Cruz - FIOCRUZ - Rio de Janeiro (RJ) - Brasil.


ABSTRACT

Purpose:

to evaluate the effects of a thickening agent on the osmolality of human milk and on an infant formula, with respect to concentration and time.

Methods:

six trials were performed to evaluate the osmolality of a natural and thickened infant formula, raw human milk, and pasteurized human milk. Rice cereal was used as a thickening agent (at concentrations of 2%, 3%, 5%, and 7%). Osmolality was measured using the Advanced Micro Osmometer Model 3300 after sample preparation periods of 0-60 minutes. Statistical evaluations were performed using ANOVA.

Results:

pasteurized human milk exhibited time- and concentration-dependent variation in osmolality. The osmolality of raw human milk differed among time points and between the samples with 5% and 7%, when compared to the non-thickened milk. The infant formula did not show differences in osmolality with respect to time. At time zero, there were differences in osmolality between the infant formula samples with 2%, 3%, and 5% thickener. At other time points, there were differences in osmolality between the sample with a 5% thickener and the non-thickened formula.

Conclusion:

the osmolality of diets varied over time and according to the concentration of thickener in human milk and the infant formula. However, the observed variation remained within the recommended parameters, indicating that rice cereal is a safe thickener for the feeding of infants presented with mild or moderate oropharyngeal dysphagia.

Keywords: Milk, Human; Deglutition Disorders; Thickeners; Osmolar Concentration; Viscosity

RESUMO

Objetivo:

avaliar o efeito do agente espessante na osmolalidade do leite humano e da fórmula infantil em relação às concentrações e ao efeito do tempo.

Métodos:

foram realizados 6 ensaios para avaliar a osmolalidade, ao natural e com espessamento, da fórmula infantil, leite humano ordenhado cru e pasteurizado. O cereal de arroz foi usado como agente espessante (nas concentrações de 2%, 3%, 5% e 7%). A osmolalidade foi aferida pelo The Advanced TM Micro Osmometer Model 3300 após a preparação das amostras por um período de 0-60 minutos. As diferenças significantes foram avaliadas por meio de Anova.

Resultados:

observou-se variação da osmolalidade no leite humano pasteurizado nos tempos observados e nas concentrações. O leite humano cru apresentou variação nos tempos e nas concentrações 5 e 7%, quando comparado ao leite não espessado. A fórmula infantil não mostrou diferenças na osmolalidade com relação ao tempo. No tempo zero, apresentou variações entre as concentrações de 2, 3 e 5%. Nos demais tempos, houve diferença na osmolalidade entre as amostras com concentração de 5% e a fórmula não espessada.

Conclusão:

a osmolalidade das dietas analisadas variou conforme o tempo e as concentrações para o leite humano e a formula infantil. No entanto, estas variações se mantiveram dentro dos parâmetros preconizados, indicando que o cereal de arroz é um espessante seguro para a alimentação de lactentes com disfagia orofaríngea leve ou moderada.

Descritores: Leite Humano; Transtornos de Deglutição; Espessantes; Concentração Osmolar; Viscosidade

Introduction

Dysphagia is a clinical condition affecting many newborns and infants with neurological, cardiorespiratory, digestive, and congenital anomalies, as well as premature infants. It is characterized by difficulty coordinating between sucking, breathing, and swallowing. It is not considered a disease, but a symptom or manifestation of a variety of congenital or structural abnormalities and/or clinical conditions or dysfunctions of the centers responsible for the neurophysiological control of the related structures, i.e., the oral cavity, pharynx, larynx, and esophagus1-3.

Assistance in dysphagia requires an individualized approach according to the clinical conditions. Speech-language therapy intervention involves oral sensory motor stimulation, postural organization during feeding, oral support and suction rhythm techniques, handling and management of breastfeeding, adaptation of feeding utensils, and, when necessary, changes in milk consistency4-6.

Human milk is species-specific and product-specific and is the first choice for feeding infants. It provides a unique combination of proteins, lipids, carbohydrates, minerals, vitamins, enzymes, and living cells and has firmly established nutritional, immunological, psychological, and economic benefits7,8. When an infant is not able to maintain clinical stability or is unable to swallow safely during feeding, after the exhaustion of oral stimulation techniques, the consistency of milk must be adjusted5), (9-14.

Modified diets, including the use of thickening agents, should be monitored with respect to viscosity and osmolality when provided to infants with dysphagia. In particular, it is necessary to examine modified diets for potential hyperosmolality. Hyperosmolar formulas can cause abdominal discomfort, delayed gastric emptying, cramps, diarrhea, and dehydration, and can promote the development of necrotizing enterocolitis and damage to the kidneys and the brain in infants15.

Osmolality is a measure of the quantity of osmotically active particles in a solution, expressed as the number of milliosmoles of solute per kilogram of solvent (mOsm/kg)16. The osmolality of human milk varies from 277 to 303 mOsm/L15, and the recommended osmolality of infant dairy food is less than 450 mOsm/kg (or 400 mOsm/L)17, although these parameters are currently debated in the scientific literature18.

Studies of the osmolality of human milk have typically focused in its fortification and nutritional aspects. However, little is known about the osmolality of diets that are thickened for infants with the goal of improving the coordination of suction, breathing, and swallowing. Thus, the objective of this study was to evaluate the osmolality of human milk and infant formula modified using rice cereal at various concentrations (2%, 3%, 5%, and 7%) at 37°C over a period of 60 minutes.

Methods

This experimental study was performed at the Quality Control Laboratory of the Human Milk Bank (BLH-IFF), with the approval of the Committee of Ethics in Human Research of IFF/Fiocruz under CAAE (14607113.4.0000.5269). All of the human milk samples were obtained from donors enrolled in the BLH-IFF from December 2013 to November 2017 in according with the provisions of the legislation that regulates the implantation and operation of human milk banks19. Samples of human milk selected for the study were stored at -20°C with an acidity of between 1 and 4ºD and 500-650 kcal/L.

Samples ofraw human milk andpasteurized human milk were used. During hospitalization in the neonatal intensive care unit, pasteurized human milk from the BLH-IFF is thickened and, after hospital discharge, if there is still indication, the mother may continue to thicken raw human milk at home.

Pasteurization is a thermal treatment applied to raw human milk aimed at inactivating 100% of pathogenic microorganisms as well as saprophytic bacteria or the normal microbiota. The process is performed at 62.5°C after preheating, and the duration of pasteurization depends on the volume of milk, as recommended by Board of director’s resolution (BDR) 17119.

The samples of human milk were thawed and maintained in a water bath at 37 ± 2°C. The infant formula was prepared according to the manufacturer's recommendations to obtain a volume of 30mL and was maintained in a water bath at 37 ± 2°C. The analysis of each concentration was performed separately.

The thickening agent was rice cereal mucilage, which does not contain traces of milk in its composition (Vitalon; WOW Nutrition, São Paulo, Brazil). For each concentration, the thickening agent was weighed using the Marte A500 digital scale and subsequently added to milk according to the manufacturer's recommendation. The samples were shaken manually during the preparation for 30 seconds to avoid excessive air entrainment and have better solubilization. A calibrated thermometer was used to verify thermal stability. Each trial was performed in triplicate; 32 human milk samples of 30 mL were used, for a total of 128 measurements, and 12 infant formula samples of 30 mL were used, for a total of 48 measurements.

The osmolality of infant formula without thickening and with thickening of2%, 3%, and 5% thickening agent and raw and pasteurized human milk without thickening and with thickening of 2%, 3%, 5%, and 7% thickening agent were determined over a 60-minute period at intervals of 20 minutes at 37°C, comprising 6 studies. Osmolality was measured based on freezing point depression using the Advanced Micro Osmometer Model 3300 (Advanced Instruments, Inc., Norwood, MA, USA). The equipment was calibrated with quality control calibration standards (Advanced Instruments Inc.) after every 10 measurements.

Descriptive analyses were performed using means and standard deviation. Normality was verified by the Kolmogorov-Smirnov (KS) and Shapiro-Wilk tests. Analysis of variance (ANOVA) was used to verify significant differences in parameters with respect to the degree of thickening. A post-hoc Tukey test was used to evaluate pairwise differences. All analyses were implemented in SPSS 21, adopting a significant level of 0.05.

Results

Without the addition of a thickener, the mean osmolality was similar for raw human milk (281 ±2.23mOsm/kg), pasteurized human milk (285 ± 1.28mOsm/kg), and an infant formula (287 ±15.43mOsm/kg) after 1 hour at 37± 2°C (Table 1).

Milk samples thickened with rice cereal exhibited a mean osmolality of 341 ±16.2mOsm/kg.

Table 1: Mean osmolality of various milk samples incubated at 37°C 

Type of milk Mean O (mOsm/kg) Standard deviation Minimum O (mOsm/kg) Maximum O (mOsm/kg)
Raw human milk 281 ±2.23 278 283
Pasteurized human milk 285 ±1.28 283 286
Infant formula 287 ±15.43 264 300
Raw human milk, 2% thickener 320 ±9.87 306 328
Raw human milk, 3% thickener 325 ±12.44 308 336
Raw human milk, 5% thickener 347 ±23.16 313 362
Raw human milk, 7% thickener 353 ±22.15 324 375
Pasteurized human milk, 2% thickener 325 ±9.08 314 335
Pasteurized human milk, 3% thickener 309 ±19.28 281 323
Pasteurized Human milk, 5% thickener 368 ±26.39 332 391
Pasteurized human milk, 7% thickener 379 ±34.97 332 408
Infant formula, 2% thickener 338 ±6.88 329 346
Infant formula, 3% thickener 331 ±10.02 320 343
Infant formula, 5% thickener 362 ±3.79 357 365

O = osmolality (mOsm/kg)

In the infant formula trial, there were no differences in osmolality among time periods for all concentrations (p>0.05). Considering the concentrations, at time zero, we observed differences in osmolality between the formula without a thickening agent and those with various concentrations of the thickening agent (p<0.05). At all other time points, there was a difference between formula prepared without a thickening agent and with 5% thickener (p = 0.009, 0.010, and 0.015, respectively, at 20, 40, and 60 minutes). There were no significant differences in osmolality among the other concentrations (2%, 3%, and 5%) (Table 2).

Table 2: Effect of time on the osmolality of an infant formula with and without thickener during incubation at 37°C 

Time (minutes) O (mOsm/kg) without thickener O (mOsm/kg) at 2% O (mOsm/kg) at 3% O (mOsm/kg) at 5%
0 264.33 ± 19.35 329.33 ± 23.71 320.33 ± 26.50 356.67 ± 5.86
20 289.67 ± 22.19 337 ± 27.22 326.33 ± 20.60 364.67 ± 7.51
40 292 ± 22.72 339.33 ± 26.27 334.67 ± 16.50 364.67 ± 12.70
60 300 ± 23.52 346 ± 20.81 343.33 ± 18.34 361.33 ± 5.51
p-value 0.293 0.870 0.581 0.628

O = osmolality (mOsm/kg) Statistical analysis: Anova test

0% vs. 2%, p = 0.000 2% vs. 3%, p = 0.827

0% vs. 3%, p = 0.000 2% vs. 5%, p = 0.020

0% vs. 5%, p = 0.000 3% vs. 5%, p = 0.002

In the trial with pasteurized human milk, we observed that there was no variation among time points in the osmolality of unmodified milk samples (p > 0.05). For samples with 2% thickener, the osmolality differed between samples obtained at times 0 and 60 minutes (p <0.05), and there were no differences between other time points. For samples with 3% thickener, we detected differences between 0 and 20 minutes, 0 and 40 minutes, and 0 and 60 minutes (p < 0.001), but no differences between the other time points. The 5 and 7% concentrations showed the same behavior in relation to time, i.e., there were no differences only between 40 and 60 minutes (p =0.125 and 0.920, respectively), indicating stabilization.

Regarding the concentrations, we also observed a difference in unmodified pasteurized human milk among the 2%, 3%, 5% and 7% concentrations, except at times zero and 20 for the 3% concentration (p = 0.976). In samples with modified viscosity, there were differences between samples with 2% and 3%, 3% and 5%, and 3% and 7% thickener at time zero (p < 0.05). At the other times, there were no differences between 2% and 3% (p = 0.932, 0.873, and 0.547) and 5% and 7% (p = 0.940, 0.224, and 0.286), respectively, at 20, 40, and 60 minutes (Table 3).

Table 3: Effect of time on the osmolality of pasteurized human milk with and without a thickening agent, incubated at 37ºC 

Time (minutes) O (mOsm/kg) without thickener O (mOsm/kg) at 2% O (mOsm/kg) at 3% O (mOsm/kg) at 5% O (mOsm/kg) at 7%
0 285.5 ± 17.75 314.33 ± 5.69 281 ± 5.20 331.67 ± 1.53 332 ± 6.08
20 283.25 ± 19.14 321.33 ± 4.62 313 ± 4.58 364.67 ± 4.62 372.67 ± 18.23
40 284.75 ± 16.92 328.67 ± 8.50 320.33 ± 7.57 382.67 ± 3.06 402.67 ± 8.39
60 286.25 ± 15.69 335.33 ± 9.07 322.67 ± 2.08 391.33 ± 6.03 408.33 ± 7.02
p-value 0.995 0.035 0.000 0.000 0.000

O = osmolality (mOsm/kg) Statistical analysis: Anova test

0% vs. 2%, p = 0.000 2% vs. 5%, p = 0.000

0% vs. 3%, p = 0.032 2% vs. 7%, p = 0.000

0% vs. 5%, p = 0.000 3% vs. 5%, p = 0.000

0% vs. 7%, p = 0.000 3% vs. 7%, p = 0.000

2% vs. 3%, p = 0.383 5% vs. 7%, p = 0.690

In an analysis of the osmolality of raw human milk with respect to time, we observed that milk without thickening and with thickening of 2% and 7% thickener did not vary over time (p>0.05). When we compared the samples with 3% and 5% thickener, we observed differences between 0 and 40 minutes (p = 0.023 and 0.029, respectively) and between 0 and 60 minutes (p = 0.010 and 0.030, respectively). Considering the concentrations, at time zero, we detected a difference between samples without thickening and with thickening of 7% thickener (p = 0.012). At the other time points, we observed a difference between samples with 5% and 7% thickener (p <0.05). Samples with other concentrations did not differ with respect to osmolality (p>0.05) (Table 4).

Table 4: Effect of time on the osmolality of raw human milk with and without the addition of a thickener, incubated at 37°C 

Time (minutes) O (mOsm/kg) without thickener O (mOsm/kg) at at 2% O (mOsm/kg) at 3% O (mOsm/kg) at 5% O (mOsm/kg) at 7%
0 279.25 ± 18.39 306.33 ± 0.58 308 ± 1.00 313.33 ± 11.24 323.67 ± 21.50
20 280 ± 15.47 320.67 ± 24.79 322.67 ± 12.50 351 ± 15.72 348.33 ± 25.11
40 282.25 ± 22.20 326 ± 19.47 332 ± 6.24 362.33 ± 23.29 363.33 ± 27.43
60 292.25 ± 29.96 328.33 ± 24.11 336 ± 7.00 362 ± 13.89 375 ± 25.24
p-value 0.829 0.556 0.010 0.021 0.146

O = osmolality (mOsm/kg) Statistical analysis: Anova test

0% vs. 2%, p = 0.000 2% vs. 5%, p = 0.033

0% vs. 3%, p = 0.000 2% vs. 7%, p = 0.006

0% vs. 5%, p = 0.000 3% vs. 5%, p = 0.104

0% vs. 7%, p = 0.000 3% vs. 7%, p = 0.024

2% vs. 3%, p = 0.989 5% vs. 7%, p = 0.974

Discussion

In this study, the impact of rice cereal, which is used as a thickener for infants with dysphagia, on the osmolality of human milk and milk formula was systematically evaluated with respect to concentration and time. The time variable was an important determinant of variation in osmolality among human milk samples. The infant formula showed increased stability over time. The variation in osmolality among samples with different concentrations of thickener was greater for pasteurized human milk than for raw human milk and an infant formula, which only exhibited differences between the thickened and non-thickened diet.

The pasteurization did not alter the osmolality of the milk samples analyzed in this study, consistent with the findings of Braga and Palhares20 who also did not observe significant differences in this parameter. Thus, variations observed in human milk may be associated with the presence of the amylase enzyme. Amylase in human milk can cause the hydrolysis of starch and consequently can result in a concentration- and time-dependent increase in osmolality21. The differences observed among the infant formula samples were associated with the concentration of thickener, because the differences began to be noticed when the concentration of the thickener varied.

Srinivasan et al.22 suggested that hyperosmolar diets are associated with necrotizing enterocolitis. An understanding of the factors influencing osmolality has important clinical implications, i.e., for understanding the diffusion of substances through cell membranes and the pressure exerted by solutes, i.e., to analyze body water balance23.

Choi et al.18 analyzed the effect of time on the osmolality of fortified breast milk and carbohydrate supplementation for a period of 24 hours at 4°C and verified that increased osmolality can be attributed to amylase enzyme activity.

However, despite substantial variation, the osmolality of human milk remained within the recommended values reported in the literature15,17,18,21 for safe use, suggesting that rice cereal supplementation is a potential therapeutic feeding strategy for infants with mild or moderate oropharyngeal dysphagia. Human milk is a protective factor for infants with dysphagia because until approximately 6 months of age, the amylase enzyme involved in the hydrolysis of the starch is lacking or present in small quantities; this enzyme is obtained via human milk which aids in the digestion of the starch24.

The use of thickening agents should be widely discussed among the care team to assess their need after the exhaustion of therapeutic techniques for the stimulation of oral and feeding functions. Immediate use after the addition of the thickener, with feeding equipment that enables measurements, can minimize negative effects and preserve the consistency and osmolality.

Evaluations of osmolality and a previous study of viscosity25 were performed by the National Institute of Women, Children, and Adolescents Health Fernandes Figueira (IFF), the maternal and child unit of Oswaldo Cruz Foundation (FIOCRUZ), which is certified as a "Baby Friendly Hospital" (BFH)26, which encourages breastfeeding and also has a Human Milk Bank. It is a reference center of the Global Network of Human Milk Banks in Brazil (nHMB), operating in Latin America, Central America, the Iberian Peninsula, and Africa. It improves the services of a maternal-infant referral hospital, with full support for breastfeeding, regardless of the pathophysiological conditions of its patients, a factor that made this study feasible.

A major motivation for this work was the fact that the thickening agent standardized by IFF apparently has a viscosity and osmolality that do not change over time. Most previous studies, based on a literature search, have focused on human milk fortification and nutritional aspects, and not on analyses of the osmolality of thickened diets for infants with respect to time, temperature, and concentration, despite the important implications for the coordination of sucking, breathing, and swallowing. The results of this study demonstrated that human milk and a thickened infant formula can be considered safe from the point of view of osmolality.

Human milk is a species-specific product, and its composition varies throughout breastfeeding and depending on the maternal characteristics, gestational period, and bioactive compounds27 capable of reacting with the thickening agent. These biological variations may interfere in the variability of the results. One way to minimize this variation is to increase the sample size. However, the complexity of controlling all variables that interfere in its characteristics would require an analysis of a huge amount of milk samples, with no guarantee of reproducibility of results.

Conclusion

The osmolality of the diets analyzed in this study varied according to the time and the concentrations for human milk and the infant formula. However, these variations remained within the recommended parameters in the literature. Thus, the diets are safe for the feeding of newborns and infants with mild or moderate oropharyngeal dysphagia.

Thickeners should be used with caution, with a focus on the minimal acceptable parameters, to ensure safety. Viscosity and osmolality are directly related, accordingly, the greater the viscosity, the greater the osmolality and the greater the adverse effects.

Acknowledgments

The authors thank the professionals of the Human Milk Bank of the Fernandes Figueira National Institute of Women, Child and Adolescent Health - Oswaldo Cruz Foundation that allowed contacting the donors and collecting the samples.

REFERENCES

1. Logemann J. Evaluation and treatment of swallowing disorders. Austin: Pro-Ed; 1998. [ Links ]

2. Cuenca RM, Malafaia DT, Souza GD, Souza LRQ, Motta VP, Lima MRA et al. Síndrome disfágica. ABCD Arq Bras Cir Diag. 2007;20(2):116-8. [ Links ]

3. Fussi C, Furkim AM. Disfagias infantis. In: Furkim AM, Santini CRQS (orgs). Disfagias orofaríngeas. São Paulo: Editora Pró-Fono; 2008. Vol 2. p. 89-114. [ Links ]

4. Hernandez AM. Neonatos. In: Jotz GP, Angelis EC, Barros APB. Tratado de deglutição e disfagia no adulto e na criança. São Paulo: Editora Revinter; 2009. p. 230-8. [ Links ]

5. Dusick A. Investigation and management of dysphagia. Semin Pediatr Neurol. 2003;10(4)255-64. [ Links ]

6. Gosa M, McMillan L. Therapeutic considerations for children and infant with feeding tubes. Perspectives on Swallowing and Swallowing Disorders. 2006;15(3):15-20. [ Links ]

7. Almeida JAG. Amamentação: um híbrido natureza-cultura. Rio de Janeiro: Editora Fiocruz; 1999. [ Links ]

8. World Health Organization. Effect of breastfeeding on infant and child mortality due to infectious disease in less developed countries: a pooled analysis. Collaborative study team on the role of breastfeeding on the prevention of infant mortality. Lancet. 2000;355(9202):451-5. [ Links ]

9. Lefton-Greif MA. Pediatric dysphagia. Phys Med Rehabil Clin N Am. 2008;19(4):837-51. [ Links ]

10. Ross ES. Feeding in the NICU and issues that influence success. Perspectives on Swallowing and Swallowing Disorders. 2008;17(3):94-100. [ Links ]

11. Goldani HAS, Silveira TR. Disfagia na infância. In: Jotz GP, Angelis EC, Barros APB (orgs). Tratado de deglutição e disfagia no adulto e na criança. São Paulo: Editora Revinter; 2009; p. 219-29. [ Links ]

12. Kakodkar K, Schroeder JW Jr. Pediatric dysphagia. Pediatr Clin N Am. 2013;60(4):969-77. [ Links ]

13. Steele CM, Alsanei WA, Ayanikalath S, Barbon CEA, Chen J, Cichero JA et al. The influence of food texture and liquid consistency modification on swallowing physiology and function: a systematic review. Dysphagia. 2015;30(1):2-26. [ Links ]

14. Dion S, Duivestein JA, Pierre AS, Harris SR. Use of thickened liquids to manage feeding difficulties in infants: a pilot survey of practice patterns in Canadian pediatric centers. Dysphagia. 2015;30(4):457-72. [ Links ]

15. Weffort VRS. Avanços nutricionais em fórmulas infantis. Pediatria Moderna. 2012;48(4):115-20. [ Links ]

16. Scott-Stump S, Mahan KL, Raymond JL. Krause alimentos, nutrição e dietoterapia. 13th ed. Rio de Janeiro: Saunders Elsevier; 2013. [ Links ]

17. Thatrimontrichai A, Janjindamai W. Safety of superfortification of human milk for preterm. Asian Biomed. 2011;5(6):825-30. [ Links ]

18. Choi A, Fusch G, Rochow N, Fusch C. Target fortification of breast milk: predicting the final osmolality of the feeds. PLoS ONE. 2016;11(2):1-12. [ Links ]

19. Agência Nacional de Vigilância Sanitária (ANVISA). Resolução RDC nº171 dispõe sobre o regulamento, a implantação e o funcionamento de Bancos de Leite Humano no território nacional. Diário Oficial da União de 04/09/2006. Brasil. [ Links ]

20. Braga LPM, Palhares DB. Effect of evaporation and pasteurization in the biochemical and immunological composition of human Milk. Jornal de Pediatria. 2007;83(1):59-63. [ Links ]

21. Grance TRS, Serafin PO, Thomaz DMC, Palhares DB. Aditivo homólogo para a alimentação do recém-nascido pré-termo de muito baixo peso. Rev Paul Pediatr. 2015;33(1):28-33. [ Links ]

22. Srinivasan L, Bokiniec R, King C, Weaver G, Edwards AD. The increased osmolality of breast milk therapeutic additives. Arch Dis Child Fetal Neonatal Ed. 2004;89:514-517. [ Links ]

23. Lewis SL, Heitkemper MM, Dirksen SR, Bucher L, Camera IM. Tratado de enfermagem médico-cirúrgica: avaliação e assistência dos problemas clínicos. 8ª edição. Mosby Elsevier; 2013: vol 1. [ Links ]

24. Fanaroff AA, Fanaroff JM. Alto risco em neonatologia. Rio de Janeiro: Editora Elsevier; 2015. p.147-97. [ Links ]

25. Almeida MBM, Gomes Junior SC, Silva JB, Silva DA, Moreira MEL. Study on viscosity modification of human and formula milk for infants. Rev. CEFAC. 2017;19(5):683-9. [ Links ]

26. Fundo das Nações Unidas para a Infância. Iniciativa Hospital Amigo da Criança: revista, atualizada e ampliada para o cuidado integrado: módulo 1: histórico e implementação / Fundo das Nações Unidas para a Infância. Brasília: Ministério da Saúde; 2008, p. 78. [ Links ]

27. Lönnerdal B. Human milk: bioactive proteins/peptides and functional properties. Nestle Nutr Ins Workshop Ser. 2016;86:97-107. [ Links ]

Received: March 22, 2018; Accepted: August 10, 2018

Corresponding adress: Mariangela Bartha de Mattos Almeida, Instituto Nacional de Saúde da Mulher, da Criança e do Adolescente Fernandes Figueira- IFF/ Fundação Oswaldo Cruz - FIOCRUZ, Setor de Fonoaudiologia Hospitalar, Avenida Rui Barbosa,716 - Flamengo, CEP:22250-020 - Rio de Janeiro, Rio de Janeiro, Brasil, E-mail: marianbartha@iff.fiocruz.br

Conflict of interests: Nonexistent

Creative Commons License This is an open-access article distributed under the terms of the Creative Commons Attribution License